Sai Teja Drugs And Intermidiates Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2000.
2000 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Sai Teja Drugs And Intermidiates Private Limited

Sai Teja Drugs And Intermidiates Private Limited, a active private limited company, was established on 21 August 2000 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2000PTC035154. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Sgvs Pharma Private Limited. It upholds a compliant status. Employing 17 professional, Its leadership includes Chandrasekhara Reddy Kallam (Director), Latha Kallam (Director), Bhargav Reddy Kallam (Director). Past directors included Addanki Siva Rama Prasad, Gade Bakki Reddy, Jaganmohanreddy Veeravenkata Nallamilli. It holds ₹8.50 Cr open charges and ₹3.86 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 39 & 40, S. V. Co-Op Industrial Estate Ida, Jeedimetla, Hyderabad, Telangana, 500055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2000PTC035154

  • Registration Number

    035154

  • Incorporation Date

    21 August 2000

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 25 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.50 Cr
  • Satisfied Charges ₹ 3.86 Cr
  • Revenue Growth **** 9.92%
  • Profit Growth **** -177.96%
  • Ebitda **** -219.06%
  • Net Worth -9.97%
  • Total Assets **** 9.49%
Company report

Sai Teja Drugs And Intermidiates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sai Teja Drugs And Intermidiates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sai Teja Drugs And Intermidiates Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandrasekhara Reddy Kallam Director 07 Mar 2007 Current
Latha Kallam Director 15 Jan 2011 Current
Bhargav Reddy Kallam Director 27 Dec 2010 Current
Saroja Konda Director 04 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Jan 2011 Past
Pramod Abcsdd Director 03 Jan 2011 Past
Pramod Abcsdd Director 26 Jul 2007 Past
Pramod Abcsdd Director 25 Jul 2007 Past
Pramod Abcsdd Director 03 Jan 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sai Teja Drugs And Intermidiates.

Sai Teja Drugs And Intermidiates Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.92% increase. The company also saw a substantial fall in profitability, with a 177.96% decrease in profit. The company's net worth dipped by a decrease of 9.97%.

Sai Teja Drugs And Intermidiates revenue growth over time
Sai Teja Drugs And Intermidiates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.92%
*******
*******
*******
*******
Revenue from Operations
*******
 9.92%
*******
*******
*******
*******
Total Assets
*******
 9.49%
*******
*******
*******
*******
Profit or Loss
*******
 -177.96%
*******
*******
*******
*******
Net Worth
*******
 -9.97%
*******
*******
*******
*******
EBITDA
*******
 -219.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sai Teja Drugs And Intermidiates?

Unlock access to Sai Teja Drugs And Intermidiates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹85,000,000.00

Satisfied Charges

₹38,600,000.00

Charges Breakdown by Lending Institutions
  • Bank Of Baroda : 8.50 Cr
Latest Charge Details
Date Lender Amount Status
15 Nov 2012 Bank Of Baroda ₹8.50 Cr Open
26 Mar 2009 Andhra Pradesh State Financial Corporation ₹3.06 Cr Satisfied
29 Apr 2004 Lord Krishna Bank Ltd ₹5.00 M Satisfied
19 Aug 2002 Andhra Bank ₹1.00 M Satisfied
15 Mar 2002 Andhra Bank ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sai Teja Drugs And Intermidiates?

Sai Teja Drugs And Intermidiates has a workforce of 17 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sai Teja Drugs And Intermidiates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Teja Drugs And Intermidiates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sai Teja Drugs And Intermidiates
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sai Teja Drugs And Intermidiates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Sai Teja Drugs And Intermidiates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Saroja Konda was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Bank Of Baroda of Rs. 8.50 Cr registered on 15 Nov 2012 with Charge ID 10390650 was modified on 01 Mar 2013. was documented.

  • Charges

    Progress on A charge registered on 26 Mar 2009 via Charge ID 10153476 with Andhra Pradesh State Financial Corporation was fully satisfied on 23 Nov 2012. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 8.50 Cr with Charge ID 10390650 was registered on 15 Nov 2012. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sai Teja Drugs And Intermidiates Private Limited?

The CIN of Sai Teja Drugs And Intermidiates Private Limited is U24239TG2000PTC035154.

Where is Sai Teja Drugs And Intermidiates Private Limited headquartered?

Sai Teja Drugs And Intermidiates Private Limited is headquartered at Plot No 39 & 40, S. V. Co-Op Industrial Estate Ida, Jeedimetla, Hyderabad, Telangana, 500055.

When was Sai Teja Drugs And Intermidiates Private Limited incorporated?

Sai Teja Drugs And Intermidiates Private Limited was incorporated on 21 August 2000.

Who are the current directors of Sai Teja Drugs And Intermidiates Private Limited?

The current directors of Sai Teja Drugs And Intermidiates Private Limited are

What is the primary industry of Sai Teja Drugs And Intermidiates Private Limited?

The primary industry of Sai Teja Drugs And Intermidiates Private Limited is Manufacturing.

Is Sai Teja Drugs And Intermidiates Private Limited a listed company?

Sai Teja Drugs And Intermidiates Private Limited is unlisted.

What is the capital structure of Sai Teja Drugs And Intermidiates Private Limited?

The authorized capital of Sai Teja Drugs And Intermidiates Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Sai Teja Drugs And Intermidiates Private Limited?

The compliance status of Sai Teja Drugs And Intermidiates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available